Skip to main content

Intrarosa FDA Approval History

FDA Approved: Yes (First approved November 17, 2016)
Brand name: Intrarosa
Generic name: prasterone
Dosage form: Vaginal Inserts
Company: Endoceutics Inc.
Treatment for: Dyspareunia

Intrarosa (prasterone) is a once-daily, vaginally administered steroid indicated to treat postmenopausal women experiencing moderate to severe pain during sexual intercourse (dyspareunia) as a symptom of vulvar and vaginal atrophy.

Development timeline for Intrarosa

Nov 17, 2016Approval FDA Approves Intrarosa (prasterone) for Postmenopausal Women Experiencing Dyspareunia

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.